What's new

Human medicines European public assessment report (EPAR): Voxzogo, vosoritide, Date of authorisation: 26/08/2021, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Voxzogo, vosoritide, Date of authorisation: 26/08/2021, Revision: 5, Status: Authorised

Mar 20, 2025 - 09:28
 0
Human medicines European public assessment report (EPAR): Voxzogo, vosoritide, Date of authorisation: 26/08/2021, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Voxzogo, vosoritide, Date of authorisation: 26/08/2021, Revision: 5, Status: Authorised
Read More

Tags:

Previous Article

AFAI calls upon Trump admin to streamline AV regulations

Next Article

249,000 retail jobs lost in five years

Related Posts

EMEA-003404-PIP01-23

EMEA-003404-PIP01-23

Feb 17, 2025  0

Human medicines European public assessment report (EPAR): CellCept, mycophenolate mofetil, Date of authorisation: 14/02/1996, Revision: 40, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 17, 2025  0

Orphan designation: Upifitamab rilsodotin Treatment of ...

Mar 12, 2025  0